Navigation Links
Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
Date:5/1/2012

s reporting more than one side effect. Most side effects were mild. Late side effects of SABR consisted of radiation pneumonitis in two percent of patients and rib fractures in three percent of patients.  

The study authors conclude that NSCLC patients with potentially operable disease who underwent SABR had an excellent outcome after SABR.  "This finding supports ongoing randomized studies comparing surgery and SABR in patients with operable stage I NSCLC," said Dr. Slotman.

In another presentation, Jeffrey Bradley, M.D., professor of radiation oncology at Washington University in St. Louis, provided an overview of a phase III randomized trial that is now accruing patients and will attempt to compare surgery with stereotactic body radiotherapy (SBRT) more systematically.  SBRT is a term used interchangeably with SABR; both refer to a method of treating a tumor with a carefully shaped and precisely targeted high-energy radiation beam to damage tumor cell DNA and kill the cancer cell. The trial is being jointly sponsored by the American College of Surgeons Oncology Group (ACOSOG) and by the Radiation Therapy Oncology Group (RTOG), two organizations that manage nationwide cancer treatment studies.

"The earlier side-by-side comparisons, such as the study by Dr. Slotman and his colleagues, have suggested that SBRT provides similar overall and cause-specific survival rates compared to surgery," said Dr. Bradley.  "However, these studies use non-randomized data and often compared a relatively healthy population of patients who had surgery with a less healthy, population treated using SBRT.  The ACOSOG/RTOG trial seeks to balance the health of patients in both study arms to determine more definitively whether surgery and SBRT provide similar cure and toxicity rates.  This is a very important study because it will help to define the optimal management of patients with early-stage lung cancer," Dr. Bradley added.

The
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
2. TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry
3. Retrospective Analysis Explores LYSTEDA®s Ability to Reduce Sleep Interruptions in Women With Cyclic Heavy Menstrual Bleeding
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... -- Registration is officially open for MEDTEC China South 2015, ... Shenzhen Convention & Exhibition Center. The Shenzhen ... the MEDTEC China family of events. MEDTEC China South, an ... serve the South China market through ... region for China,s medical device industry. ...
(Date:3/3/2015)... 2015  RedHill Biopharma Ltd. (NASDAQ/TASE: RDHL) ... company primarily focused on late clinical-stage, proprietary, ... including gastrointestinal cancers, today announced that ... will be presenting at VirtualInvestorConferences.com, a live ... 5, 2015, at 10:00 am EST. ...
(Date:3/3/2015)... , March 3, 2015 - ... 26 June 2015, SNIEC, Shanghai, China ... 10th P-MEC China, will be held at Shanghai New International ... P-MEC China originated from CPhI Worldwide and was introduced to ... important bridge between Chinese pharmaceutical companies and global pharmaceutical industry ...
Breaking Medicine Technology:Pre-registration Open for 2015 MEDTEC China South 2Pre-registration Open for 2015 MEDTEC China South 3RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 2RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 3RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015 415th Anniversary, Be Part of Chinese Pharma Dream 215th Anniversary, Be Part of Chinese Pharma Dream 3
... board of directors of Eli Lilly and Company (NYSE: LLY ... $0.49 a share on outstanding common stock. This is the same dividend ... the total annual dividend for 2011 to $1.96 per share. ... the close of business on November 15, 2011. About ...
... Verisk Health ... Solutions suite to include greater predictive power and reporting ... International Classification of Diseases, Tenth Revision, Clinical Modification ... models that predict emergency department (ED) utilization and measure practice ...
Cached Medicine Technology:Verisk Health's DxCG Risk Solutions Technology Ready to Support Industry Adoption of ICD-10-CM 2
(Date:3/3/2015)... The number of couples experiencing infertility in ... This increases to 50% by the time a woman ... AA, et al. Estimating the prevalence of infertility in ... a reproductive endocrinologist and co-director at Olive Fertility Centre, ... director and founder of Acubalance Wellness Centre will be ...
(Date:3/3/2015)... The North America application delivery ... $1,224.6 million to $1,694.6 million, at a ... , Browse through the TOC of North ... analysis of industry trends and segments, with ... http://www.micromarketmonitor.com/market/north-america-application-delivery-network-adn-7381582251.html , An application delivery ...
(Date:3/3/2015)... 2015 Splashtop Inc. , the ... is now available for Epson® MoverioTM BT-200 smart glasses. ... Moverio Apps Market , iPod, iPhone, and iPad users ... the Epson Moverio smart glasses using Mirroring360, enhancing the ... , The Epson smart glasses have an advanced binocular ...
(Date:3/3/2015)... 2015 OncLive® and Indiana University ... forces to share news about the center’s research ... is part of OncLive’s Strategic Alliance Partnership initiative. ... and marketing teams will partner with the IU ... center, to highlight accomplishments. They include the center’s ...
(Date:3/3/2015)... 03, 2015 Celestix Networks, the ... today announced the global availability of Celestix Cloud ... the world’s most deployed platform for DirectAccess and ... R2. This new release enables organizations to manage ... from a single HTML 5 web interface called ...
Breaking Medicine News(10 mins):Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 2Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 3Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 4Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 2Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 3Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 2Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 3Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 2Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 3Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 2Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 3
... 1, 2008 -- 11 a.m. news event -- Hall of ... DC 20001 , , WASHINGTON, ... coming together to outline the current fiscal situation states are ... a recovery package that will spur job growth, support infrastructure ...
... 1 An independent study at the,University of Cumbria found that ... same time as exercising. The games reduce the boredom of,exercise. , ... 12 were asked to use exercise equipment,combined with video games provided ... The children could play their games only while they maintained ...
... Calif., Dec. 1 Transcept Pharmaceuticals,Inc., a privately-held specialty ... Chief Executive Officer, is scheduled to,participate at the RBC ... a panel entitled "Delivering Novel Drug Solutions: The Future ... place on Thursday, December,11, 2008 at 1:30 PM Eastern ...
... Ohio and TAMPA, Fla., Dec. 1 Cardinal,Health and ... agreement to offer surgical kits that include disposable health,care ... from SRI,Surgical. , ... SRI,Surgical,s complete line of more than 400 disposable surgical ...
... can prevent spread of infection , , MONDAY, Dec. 1 (HealthDay ... and older for HIV, says a new practice guideline released ... the virus that causes AIDS. , In the United ... 20,000 new infections are caused each year by people who ...
... Acuo Technologies(R), developers,of high-performance software for intelligent ... announced the contracting with Rush,University Medical ... neutral archiving,solution which becomes the basis of the ... is based on the Acuo Technologies DICOM,Services Grid(TM) ...
Cached Medicine News:Health News:Governors, Legislators Update Current State Fiscal Conditions, Push for Economic Recovery Package from Congress, President-elect 2Health News:Children Tell Researchers: We'll Get Fit if It's Fun 2Health News:Transcept Pharmaceuticals to Participate on Drug Delivery Investor Panel 2Health News:Cardinal Health, SRI Surgical Sign Five-Year Agreement For Surgical Kits 2Health News:Cardinal Health, SRI Surgical Sign Five-Year Agreement For Surgical Kits 3Health News:Guideline Urges HIV Tests for All Patients 13 and Older 2Health News:Acuo Technologies Announces Vendor Neutral Archiving Contract With Rush University Medical Center 2Health News:Acuo Technologies Announces Vendor Neutral Archiving Contract With Rush University Medical Center 3
... ARRAY® Multifocal IOL is a foldable silicone ... PMMA haptics and is designed to be ... The ARRAY® Multifocal IOL is the first ... first to offer patients a full range ...
... 2% Hydroxypropyl Methylcellulose solution that is especially ... volume, small incision surgery. The low molecular ... removal with minimal risk of elevated intraocular ... unobstructed view of the surgical field throughout ...
... The visco-elastic ENDOGEL is a sterile, ... hyaluronate. ENDOGEL is supplied in a ... a Luer-Lock fitting, delivering 0,85 ml. ... polysaccharide composed of repetitive chains of ...
... ophthalmic viscosurgical device ... patented HPMC viscoelastic ... performance, economy and ... properties and handling ...
Medicine Products: